INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $507,000 | -14.5% | 4,289 | -3.1% | 0.03% | -21.2% |
| Q3 2021 | $593,000 | -18.1% | 4,424 | -1.0% | 0.03% | -17.5% |
| Q2 2021 | $724,000 | +262.0% | 4,470 | +79.2% | 0.04% | +233.3% |
| Q1 2021 | $200,000 | +40.8% | 2,494 | -75.9% | 0.01% | -25.0% |
| Q4 2018 | $142,000 | -48.9% | 10,367 | +6.8% | 0.02% | -48.4% |
| Q3 2018 | $278,000 | +34.3% | 9,707 | +28.0% | 0.03% | +29.2% |
| Q2 2018 | $207,000 | – | 7,581 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |